OROS-methylphenidate to reduce ADHD symptoms in male prisoners aged 16 25 years: a RCT - Efficacy and Mechanism Evaluation.

Philip Asherson*, Lena Johansson, John Strang, Sabine Landau

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

129 Downloads (Pure)
Original languageEnglish
Article number10.3310/THEI8200
Number of pages146
JournalEfficacy and Mechanism Evaluation
Issue number6
Publication statusPublished - 5 Jul 2022

Cite this